Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 11/30/2023Recent Official and Executive Moves
  • 11/28/2023Takeda China Expands Collaborations for Digital Healthcare Innovation ...
  • 11/28/2023India's Dependence on Chinese APIs Reduced to Some Extent after PLI Sc...
  • 11/28/2023Evommune and Accutar Biotech Announce AI Drug Discovery Collaboration
  • 11/28/2023CDE Solicits Comments on the Guidelines for the Acceptance and Review ...
  • 11/27/2023CDE Solicits Comments on the Detailed Rules on Adding Pediatric Inform...
  • 11/27/2023Moderna Begins Work on Its mRNA China Plant
  • 11/27/2023China's BMI Fund Tops CNY 2.6T in Revenue in First Ten Months of 202...
  • 11/27/2023Over 1B Enrollees Signed Up BMI's Digital Code System Four Year After ...
  • 11/27/2023Indian Pharma to Benefit amid Big Pharma's China De-Risking
  • 11/27/2023Coherus Sets Price of China-Made PD-1 Inhibitor Loqtorzi at a 20% Disc...
  • 11/27/2023AstraZeneca to open Hong Kong R&D centre by late 2024 at earliest with...
  • 11/27/2023CDE Solicits Comments on the Technical Guidelines for Application of D...
  • 11/26/2023CDE Issues the Guide to Compilation of Drug Package Inserts (Abbreviat...
  • 11/26/2023NHSA Issues New Doc to Strengthen and Enhance Drug Price and Tender Cr...
  • 11/26/2023Dizal Strikes Derma Drug JV Deal with Wuxi High-tech Zone
  • 11/26/2023Zhifei to Acquire Chenan to Expand into Metabolic Disease Drugs
  • 11/24/2023Recent Executive Moves
  • 11/24/2023Drug R&D and Product Registration News Digest 11/2023 (2)
  • 11/24/2023CDE Solicits Comments on the Technical Guidelines for Application of D...
  • 11/24/2023China Concludes Tendering Process of 9th VBP amid Reform to Improve ...
  • 11/23/2023State Council Approves the Draft Implementation Rules of the Patent L...
  • 11/23/2023CDE Solicits Comments on the Technical Guidelines for Safety Informati...
  • 11/23/2023CDE Solicits Comments on the Guidelines for BE Studies of Dydrogestero...
  • 11/23/2023Myricx Concludes Global Licence Deal for WuXi Bio's Antibody
  • 11/22/2023Acrometa to Strengthen Biopharma Presence in China by Developing Co-Wo... (Free)
  • 11/21/2023Tencent Sets Sights on China's Multibillion-Dollar Healthcare Sector w...
  • 11/21/2023Bimeda Opens £22M China Plant
  • 11/21/2023Connect Bio and Simcere Pharma Announce Exclusive License Deal for Rad...
  • 11/21/2023AstraZeneca and Usynova Strike Global License Deal for KRASG12D Inhib...
  • Page:37/38 Total number of articles:1126: [First][<<] [34] [35] [36] [37] [38] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group